SHL Telemedicine Ltd. EBITDA for the year ending December 31, 2024: USD -18.15 M

SHL Telemedicine Ltd. EBITDA is USD -18.15 M for the year ending December 31, 2024, a -700.23% change year over year. EBITDA means earnings before interest, taxes, depreciation, and amortization, which measures a company's operating performance by excluding non-operating expenses.
  • SHL Telemedicine Ltd. EBITDA for the year ending December 31, 2023 was USD 3.02 M, a -68.10% change year over year.
  • SHL Telemedicine Ltd. EBITDA for the year ending December 31, 2022 was USD 9.48 M, a 117.91% change year over year.
  • SHL Telemedicine Ltd. EBITDA for the year ending December 31, 2021 was USD 4.35 M, a -19.59% change year over year.
  • SHL Telemedicine Ltd. EBITDA for the year ending December 31, 2020 was USD 5.41 M, a -39.78% change year over year.
Key Data
Date EBITDA Net Income EPS (Diluted) Shares (Diluted, Weighted)